News in brief: MedReleaf expands product range; Bioxyne receives first psilocybin order; Greencare names medical lead by Steve Jones February 11, 2026June 8, 2026 MedReleaf Australia has expanded its product range in Australia and New Zealand with the addition of […]
Bioxyne enters Central American markets with pastille supply deal by Steve Jones December 12, 2025December 12, 2025
‘Not a revenue grab’: Curaleaf International CEO maps out Australian expansion plan by Adam Sheldon November 27, 2025December 2, 2025
News in brief: Legalise Cannabis ramps up criticism of Victorian government; MCA launches desktop guide for clinicians; Bioxyne secures A$1.7m for UK GMP facility by Adam Sheldon November 17, 2025February 21, 2026
News in brief: Cann completes NAB settlement; Bioxyne releases GMP-certified MDMA capsules by Adam Sheldon November 11, 2025February 21, 2026
Breathe Life Sciences launches Curaleaf medical inhalation device by Adam Sheldon November 3, 2025November 3, 2025
Record revenue for Bioxyne but cash deficit rises after flower investment by Steve Jones October 30, 2025November 3, 2025
Cannabis executive salaries: who earned what in FY25 by Adam Sheldon October 22, 2025October 22, 2025
News in brief: The Entourage Effect named AFR innovation finalist; Bioxyne lists in Germany; Nimbin to host medical cannabis symposium by Steve Jones October 13, 2025February 21, 2026
